AI assistant
Sending…
iBio, Inc. — Director's Dealing 2025
Jan 13, 2025
35045_dirs_2025-01-13_cc713499-66d6-4d02-9a82-c715e430eab8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2025-01-10
Reporting Person: Arkowitz David (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-10 | Common Stock | P | 18382 | $2.72 | Acquired | 18382 | Direct |
Footnotes
F1: Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.
More from iBio, Inc.
Regulatory Filings
2026
Jul 1
Call Transcript
2026
Jun 4
Capital/Financing Update
2026
Apr 29
Call Transcript
2026
Apr 8
Regulatory Filings
2026
Apr 8
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Call Transcript
2026
Mar 17
Call Transcript
2026
Mar 9
Capital/Financing Update
2026
Feb 27